106 related articles for article (PubMed ID: 82767)
1. Dipyridamole and platelet function.
Lancet; 1978 Dec; 2(8102):1257-9. PubMed ID: 82767
[No Abstract] [Full Text] [Related]
2. [Pharmacological action on the thromboxane and prostacyclin balance in the body].
Lakin KM; Makarov VA; Novikova NV; Tret'iak VM; Rukazenkov IuE
Farmakol Toksikol; 1984; 47(2):67-79. PubMed ID: 6425078
[No Abstract] [Full Text] [Related]
3. Lack of synergism between dazoxiben and dipyridamole following administration to man.
Gresele P; Deckmyn H; Arnout J; Zoja C; Vermylen J
Thromb Res; 1985 Jan; 37(1):231-6. PubMed ID: 3838601
[No Abstract] [Full Text] [Related]
4. [Suppression of platelet aggregation as a result of two-component inhibition of a polyenzyme system of thromboxane synthesis].
Varfolomeev SD; Lakin KM; Mevkh AT; Novikova NV; Rukazenkov IuZ
Dokl Akad Nauk SSSR; 1985; 282(1):194-6. PubMed ID: 3928305
[No Abstract] [Full Text] [Related]
5. Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.
Moncada S; Korbut R
Lancet; 1978 Jun; 1(8077):1286-9. PubMed ID: 78050
[TBL] [Abstract][Full Text] [Related]
6. A biphasic effect of prostacyclin (PGI2) on platelet aggregation.
Jørgensen KA; Dyerberg J; Stoffersen E
Thromb Res; 1980 Sep; 19(6):877-81. PubMed ID: 6258262
[No Abstract] [Full Text] [Related]
7. Dipyridamole and platelet aggregation.
Lancet; 1978 Jul; 2(8083):270. PubMed ID: 79070
[No Abstract] [Full Text] [Related]
8. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
9. Modulation of human platelet function by prostacyclin and thromboxane A2.
Gorman RR
Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
[No Abstract] [Full Text] [Related]
10. The role of prostacyclin and thromboxane A2 in the regulation of platelet behaviour.
Moncada S
Mater Med Pol; 1980; 12(3):207-12. PubMed ID: 7019591
[No Abstract] [Full Text] [Related]
11. The effects of dipyridamole on TXA2 formation by horse platelet microsomes.
Katano Y; Imai S
Prostaglandins Leukot Med; 1983 Feb; 10(2):179-85. PubMed ID: 6573686
[TBL] [Abstract][Full Text] [Related]
12. [Function of prostaglandins in platelet aggregation].
Sun QW
Sheng Li Ke Xue Jin Zhan; 1980 Feb; 11(2):137-42. PubMed ID: 7001620
[No Abstract] [Full Text] [Related]
13. Pharmacology of UK-38485 (dazmegrel), a specific inhibitor of thromboxane A2 synthetase.
Rebec MV; Skrinska VA
Prostaglandins Leukot Essent Fatty Acids; 1989 Dec; 38(3):207-12. PubMed ID: 2622975
[TBL] [Abstract][Full Text] [Related]
14. [Highlights of thromboxane synthetase inhibitor research].
Yu WG; Xu LN
Sheng Li Ke Xue Jin Zhan; 1990 Jul; 21(3):216-20. PubMed ID: 2244198
[No Abstract] [Full Text] [Related]
15. Mechanism of action of dipyridamole.
Harker LA; Kadatz RA
Thromb Res Suppl; 1983; 4():39-46. PubMed ID: 6356465
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of thromboxane synthetase inhibitors.
Smith JB
Fed Proc; 1987 Jan; 46(1):139-43. PubMed ID: 3542573
[TBL] [Abstract][Full Text] [Related]
17. Guanidine derivatives as combined thromboxane A2 receptor antagonists and synthase inhibitors.
Soyka R; Guth BD; Weisenberger HM; Luger P; Müller TH
J Med Chem; 1999 Apr; 42(7):1235-49. PubMed ID: 10197967
[TBL] [Abstract][Full Text] [Related]
18. Dipyridamole: a possible potent inhibitor of thromboxane A2 synthetase in vascular smooth muscle.
Ally AI; Manku MS; Horrobin DF; Morgan RO; Karmazin M; Karmali RA
Prostaglandins; 1977 Sep; 14(3):607-9. PubMed ID: 905584
[No Abstract] [Full Text] [Related]
19. Characterization of biochemical and functional effects of antiplatelet drugs as a key to their clinical development.
Patrono C; Patrignani P; Rocca B; Landolfi R
Thromb Haemost; 1995 Jul; 74(1):396-400. PubMed ID: 8578493
[No Abstract] [Full Text] [Related]
20. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase.
Lee JJ; Yu JY; Lee JH; Zhang WY; Kim TJ; Myung CS; Yun YP
Arch Pharm Res; 2010 Mar; 33(3):387-94. PubMed ID: 20361303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
